Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amand F Schmidt

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical Epidemiology|December 21, 2017
Linear regression and the normality assumptionAmand F Schmidt, Chris Finan
Cold Spring Harbor Perspectives in Medicine|October 15, 2021
Human Genomics and Drug DevelopmentAmand F Schmidt, Aroon D Hingorani, Chris Finan
Epidemiology (Cambridge, Mass.)|January 26, 2016
Re: Is the Risk Difference Really a More Heterogeneous Measure?Amand F Schmidt, Frank Dudbridge, Rolf H H Groenwold
Epidemiology (Cambridge, Mass.)|October 6, 2015
Adjusting for Confounding in Early Postlaunch Settings: Going Beyond Logistic Regression ModelsAmand F Schmidt, Olaf H Klungel, Rolf H H Groenwold, et al.
Communications Medicine|March 14, 2025
Identifying and ranking non-traditional risk factors for cardiovascular disease prediction in people with type 2 diabetesKatarzyna Dziopa, Nishi Chaturvedi, Folkert W Asselbergs, et al.
Statistics in Medicine|January 8, 2014
Comments on 'the use of propensity scores and observational data to estimate randomized controlled trial generalizability bias' by Taylor R. Pressler and Eloise E. Kaizar, Statistics in Medicine 2013Amand F Schmidt, Arno W Hoes, Rolf H H Groenwold
Diabetologia|January 15, 2022
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settingsKatarzyna Dziopa, Folkert W Asselbergs, Jasmine Gratton, et al.
Atherosclerosis|February 7, 2024
Prioritising genetic findings for drug target identification and validationNikita Hukerikar, Aroon D Hingorani, Folkert W Asselbergs, et al.
Alzheimer'S Research & Therapy|December 28, 2024
Correction: Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a mendelian randomization analysisAmand F Schmidt, Michael H Davidson, Marc Ditmarsch, et al.
Alzheimer'S Research & Therapy|October 16, 2024
Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysisAmand F Schmidt, Michael H Davidson, Marc Ditmarsch, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Epidemiology|December 21, 2017
Linear regression and the normality assumptionAmand F Schmidt, Chris Finan
Cold Spring Harbor Perspectives in Medicine|October 15, 2021
Human Genomics and Drug DevelopmentAmand F Schmidt, Aroon D Hingorani, Chris Finan
Epidemiology (Cambridge, Mass.)|January 26, 2016
Re: Is the Risk Difference Really a More Heterogeneous Measure?Amand F Schmidt, Frank Dudbridge, Rolf H H Groenwold
Epidemiology (Cambridge, Mass.)|October 6, 2015
Adjusting for Confounding in Early Postlaunch Settings: Going Beyond Logistic Regression ModelsAmand F Schmidt, Olaf H Klungel, Rolf H H Groenwold, et al.
Communications Medicine|March 14, 2025
Identifying and ranking non-traditional risk factors for cardiovascular disease prediction in people with type 2 diabetesKatarzyna Dziopa, Nishi Chaturvedi, Folkert W Asselbergs, et al.
Statistics in Medicine|January 8, 2014
Comments on 'the use of propensity scores and observational data to estimate randomized controlled trial generalizability bias' by Taylor R. Pressler and Eloise E. Kaizar, Statistics in Medicine 2013Amand F Schmidt, Arno W Hoes, Rolf H H Groenwold
Diabetologia|January 15, 2022
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settingsKatarzyna Dziopa, Folkert W Asselbergs, Jasmine Gratton, et al.
Atherosclerosis|February 7, 2024
Prioritising genetic findings for drug target identification and validationNikita Hukerikar, Aroon D Hingorani, Folkert W Asselbergs, et al.
Alzheimer'S Research & Therapy|December 28, 2024
Correction: Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a mendelian randomization analysisAmand F Schmidt, Michael H Davidson, Marc Ditmarsch, et al.
Alzheimer'S Research & Therapy|October 16, 2024
Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysisAmand F Schmidt, Michael H Davidson, Marc Ditmarsch, et al.
Pageof 6